BioSpace News Archive

Hemovent GmbH announced today that it has closed an extension of its Series B financing round, raising an additional $5.5 + million from existing investors led by MIG Funds . Hemovent previously announced that it had closed a $5.2 million Series B round on the expectation of a regulatory approval of its MOBYBOX™ECMO/ECLS system. MOBYBOX i

As the COVID-19 pandemic continues to affect business in every sector, Chicago-based Antlia Systems – a woman and minority-owned business and leading supplier of safety technology systems – is now offering a suite of in-demand thermal detectors to meet the unexpected and growing need nationally.

Proven Pharmaceuticals, LLC, a service provider to the healthcare and life-science industries, announced today that it is the exclusive authorized U.S. distributor of the Clungene® SARS-CoV-2 Virus (COVID-19) IgG/IgM Rapid Test Cassette.

Scientists at Cold Spring Harbor Laboratory (CSHL) have found that they can stop the growth of pancreatic cancer cells by interfering with the way the cells store cholesterol.

Respiratory Motion Inc. (RMI) today announced the appointment of Chas Taylor and Bob Smouse, MD, FACR to the Board of Directors, Chas Taylor has been named Chairman of the Board,

Today, Sensory Cloud, a technology startup that designs solutions to problems of human well-being and healthcare through pioneering discoveries at the frontiers of olfaction and respiratory biology, announced the publication of a new peer-reviewed paper in QRB Discovery,

In lieu of an in-person update to the media, Dr. Theresa Tam, Canada’s Chief Public Health Officer, issued the following statement

BioLife Solutions, Inc. (NASDAQ: BLFS) (“BioLife” or the “Company”), a leading developer and supplier of a portfolio of class-defining bioproduction tools for cell and gene therapies, today announced the closing of its public offering of 5,951,250 shares of common stock at the public offering price of $14.50 per share

CAGE Bio Inc. announced a research and development agreement with Nitto Denko Corporation for a transdermal formulation of undisclosed molecules.

As evidence showing a real risk of airborne transmission of SARS-CoV-2 (Coronavirus responsible for COVID-19) continues to mount, Integrated Viral Protection (IVP) announced today the publication of a peer-reviewed paper detailing a novel biodefense indoor air protection technology.